A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Volume 24, 2020 Articles
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
PreScription: One Size Does Not Fit All! Allen Loyd V Jr	Jan/Feb 2020 Pg. 4
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets Mulder Kyle	Jan/Feb 2020 Pg. 7-12
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Vaughn Stacey R, Radwick Allison	Jan/Feb 2020 Pg. 14-19
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Cabaleiro Joe	Jan/Feb 2020 Pg. 21-27
New and Improved! Brunner Scott	Jan/Feb 2020 Pg. 28-29
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Allen Loyd V Jr	Jan/Feb 2020 Pg. 38-43
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Allen Loyd V Jr	Jan/Feb 2020 Pg. 44-50
Calculations Stockton Shelly J	Jan/Feb 2020 Pg. 52
Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jan/Feb 2020 Pg. 54
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 55
Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup Allen Loyd V Jr	Jan/Feb 2020 Pg. 56
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Allen Loyd V Jr	Jan/Feb 2020 Pg. 57
Isoniazid 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2020 Pg. 58
LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment Allen Loyd V Jr	Jan/Feb 2020 Pg. 59
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
Potassium Chloride 1 mmol/mL in Ora-Sweet SF Allen Loyd V Jr	Jan/Feb 2020 Pg. 61
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules Allen Loyd V Jr	Jan/Feb 2020 Pg. 62
Venlafaxine 15 mg/mL in Syrup Allen Loyd V Jr	Jan/Feb 2020 Pg. 63
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M	Jan/Feb 2020 Pg. 64-68
Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution Marotta James C, Patel Gopesh, Carvalho Maria, Blakeney Samantha	Jan/Feb 2020 Pg. 69-76
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James	Jan/Feb 2020 Pg. 77-82
Compatibility of Melphalan in Iodinated Contrast Media Shi Zhanquan, Abruzzo Todd, Wanasathop Apipa, Li S Kevin	Jan/Feb 2020 Pg. 83-85
Errata - How to Qualify Container Closure Systems for Intended Use, Part 1 - IJPC 23(6) 454-461	Jan/Feb 2020 Pg. 86-87 View Sample
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Allen Loyd V Jr	Mar/Apr 2020 Pg. 92
Low-dose Naltrexone Therapy for Psoriasis Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander	Mar/Apr 2020 Pg. 94-96
Compounding Pearls -- Wound Care: Base Selection Riepl Mike	Mar/Apr 2020 Pg. 98-102
Low-dose Pilocarpine Spray to Treat Xerostomia Zur Eyal	Mar/Apr 2020 Pg. 104-108
A "North Star" for Pharmacy Compounders Brunner Scott	Mar/Apr 2020 Pg. 110-113
Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems Allen Loyd V Jr	Mar/Apr 2020 Pg. 114-118
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Allen Loyd V Jr	Mar/Apr 2020 Pg. 121-126
Calculations Stockton Shelly J	Mar/Apr 2020 Pg. 128
Acetazolamide 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 130
Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 131
Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1) Allen Loyd V Jr	Mar/Apr 2020 Pg. 132
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 133
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2020 Pg. 134
Propylthiouracil 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 135
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 136
Terbinafine 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 137
Topiramate 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 138
Valsartan 4 mg/mL in Syrup NF Allen Loyd V Jr	Mar/Apr 2020 Pg. 139
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren	Mar/Apr 2020 Pg. 140-147
Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai	Mar/Apr 2020 Pg. 148-155
Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia Sorrieul Jérémy, Robert Julien, Chapel Fanny, Gossye Thomas, Devys Catherine	Mar/Apr 2020 Pg. 156-162
Feasibility Study of Asthma Cream Kuang Andrew	Mar/Apr 2020 Pg. 163-167
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard	Mar/Apr 2020 Pg. 168-175
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2 Allen Loyd V Jr	May/Jun 2020 Pg. 180
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1 Riepl Mike	May/Jun 2020 Pg. 182-186
Compounding Pearls -- Wound Care: Burn Healing, Part 1 Riepl Mike	May/Jun 2020 Pg. 188-193
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Hagan John C III, Everett Eric, Chamberlain Tyler	May/Jun 2020 Pg. 194-197
U.S. Food and Drug Administration Takes Aim (Again) at Animal Compounding: Draft Guidance for Industry #256 Lacks Authority, Will Increase Costs, and Put Pets at Risk Brunner Scott	May/Jun 2020 Pg. 198-199
Quality Control: Photostability of Compounded Preparations Allen Loyd V Jr	May/Jun 2020 Pg. 200-205
Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents Allen Loyd V Jr	May/Jun 2020 Pg. 206-212
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Allen Loyd V Jr	May/Jun 2020 Pg. 215-220
Calculations Stockton Shelly J	May/Jun 2020 Pg. 222
Baclofen 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 224
Dexamethasone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 225
Diphenylcyclopropenone 0.1% or 3% in Isopropranol Allen Loyd V Jr	May/Jun 2020 Pg. 226
Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules Allen Loyd V Jr	May/Jun 2020 Pg. 227
Monsel's Solution, Gel, and Paste Allen Loyd V Jr	May/Jun 2020 Pg. 228
Prednisolone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 229
Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension Allen Loyd V Jr	May/Jun 2020 Pg. 230
Tetracycline Hydrochloride 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 231
Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary Allen Loyd V Jr	May/Jun 2020 Pg. 232
Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension Allen Loyd V Jr	May/Jun 2020 Pg. 233
Comparative Stability Study of Unit-dose Vancomycin Hydrochloride Oral Solutions in Plastic Capped Oral Syringes and Plastic Sealed Dosage Cups Brown Stacy, Lewis Paul	May/Jun 2020 Pg. 234-237
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions Wilder Alyson G, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A	May/Jun 2020 Pg. 238-241
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture Ngim Kenley, Patel Jalpa	May/Jun 2020 Pg. 242-245
Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara	May/Jun 2020 Pg. 246-251
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli	May/Jun 2020 Pg. 252-262
PreScription: COVID-19 and Compounding Pharmacists Allen Loyd V Jr	Jul/Aug 2020 Pg. 268
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration Greeson Nicole MH, Mixon William, Allan W Chris	Jul/Aug 2020 Pg. 270-276
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2 Riepl Mike	Jul/Aug 2020 Pg. 278-281
Compounding Pearls -- Wound Care: Burn Healing, Part 2 Riepl Mike	Jul/Aug 2020 Pg. 282-285
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic McElhiney Linda F	Jul/Aug 2020 Pg. 287-295
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Brunner Scott	Jul/Aug 2020 Pg. 296-297
Quality Control: Rapid Sterility Testing for Compounding Pharmacies Taylor Andrew	Jul/Aug 2020 Pg. 299-303
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations Allen Loyd V Jr	Jul/Aug 2020 Pg. 305-309
Calculations Stockton Shelly J	Jul/Aug 2020 Pg. 310
Benzonatate 50 mg/mL in Ora-Sweet Allen Loyd V Jr	Jul/Aug 2020 Pg. 312
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream Allen Loyd V Jr	Jul/Aug 2020 Pg. 313
Doxepin Hydrochloride 5% in Cetaphil Cream Allen Loyd V Jr	Jul/Aug 2020 Pg. 314
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 315
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Allen Loyd V Jr	Jul/Aug 2020 Pg. 316
Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2020 Pg. 317
Lisinopril 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 318
Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle Allen Loyd V Jr	Jul/Aug 2020 Pg. 319
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Allen Loyd V Jr	Jul/Aug 2020 Pg. 320
Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 321
Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula Hossain Mohammad Faisal, Levesque Dan, Frye John, Rashid Mamoon	Jul/Aug 2020 Pg. 322-326
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4 Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C	Jul/Aug 2020 Pg. 327-336
Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S	Jul/Aug 2020 Pg. 337-345
Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review Milibari Loay, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter	Jul/Aug 2020 Pg. 346-351
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Allen Loyd V Jr	Sep/Oct 2020 Pg. 356
Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol	Sep/Oct 2020 Pg. 358-364
Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna	Sep/Oct 2020 Pg. 367-369
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Greeson Nicole MH, Mixon William, Allan W Chris	Sep/Oct 2020 Pg. 371-379
Houston, We Have a Study': History-making African Research Relies on a Maverick Texas Pharmaceutical Compounder Lovell Nancy	Sep/Oct 2020 Pg. 380-385
An Unconscionable, Unnecessary Fight Brunner Scott	Sep/Oct 2020 Pg. 386-387
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants Allen Loyd V Jr	Sep/Oct 2020 Pg. 388-395
Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications Allen Loyd V Jr	Sep/Oct 2020 Pg. 397-402
Calculations Stockton Shelly J, Bui Phi H	Sep/Oct 2020 Pg. 404
Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Allen Loyd V Jr	Sep/Oct 2020 Pg. 406
Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2020 Pg. 407
Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson	Sep/Oct 2020 Pg. 408-412
Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A	Sep/Oct 2020 Pg. 413-419
Biotin Regulates Colonization and Growth of Candida albicans in the Catheter Lumen During Nutrient Infusions Ohara Hiroshi, Matsuzaki Tetsuya, Ochiai Tatsuya, Hayasaka Masataka	Sep/Oct 2020 Pg. 420-425
Efficacy of an Automated Robotic Cleaning Device for Compounding Pharmacies Polonini Hudson, Dijkers Eli CF, Ferreira Anderson O, da Silva Sharlene L, Araújo Paulo Victor C, Koulouridas Savvas	Sep/Oct 2020 Pg. 426-433
Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques Bjornstad Matthew, Kosinski Tracy, Burlage Robert	Sep/Oct 2020 Pg. 434-438
PreScription: The NASEM cBHT Report, Part 1 Allen Loyd V Jr	Nov/Dec 2020 Pg. 444
NASEM Report on Compounded Topical Pain Creams Allen Loyd V Jr	Nov/Dec 2020 Pg. 446-448
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Allen W Chris, Greeson Nicole MH, Mixon William	Nov/Dec 2020 Pg. 451-458
Establishing a Structured Pharmacy Training Program in Sterile Compounding Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq	Nov/Dec 2020 Pg. 460-465
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1 DeRosa Angela	Nov/Dec 2020 Pg. 466-470
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Allen Loyd V Jr	Nov/Dec 2020 Pg. 473-478
Calculations Drinnon Stephen D, Stockton Shelly J	Nov/Dec 2020 Pg. 480
Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use Teimouri Arezou, Yeung Pollen, Agu Remigius U	Nov/Dec 2020 Pg. 482-490
Analysis of Extemporaneously Compounded Nasal Preparations Prescribed by Latvian Otorhinolaryngologists and General Practitioners and Comparison with German Formulations Kiselova Olga, Maurina Baiba, Sidlovska Venta	Nov/Dec 2020 Pg. 491-500
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing Teimouri Arezou, Yeung Pollen, Agu Remigius U	Nov/Dec 2020 Pg. 501-508
Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract Azman Syahiera Ezzah Noor, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai	Nov/Dec 2020 Pg. 509-514
Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L. Carneiro Jaqueline, Marques Gonçalves Melissa, Vicente Pereira Airton	Nov/Dec 2020 Pg. 515-518
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure Ma Nathan, Perks William, Law Shirley, Iazzetta John, Walker Scott	Nov/Dec 2020 Pg. 519-527
Erratum: IJPC. 2020; 24(4): 327 Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF PH4	Nov/Dec 2020 Pg. 527 View Sample
Return to Top